Claudin-1 (CLDN1) is a protein usually found nestled between epithelial cells — which cover internal and external body surfaces — helping to bind them. “It works like a zipper to keep two ...
Alentis Therapeutics SA is poised to expand its reach in Claudin-1 biology, after closing a $181.4 million series D that will fund phase I/II trials of two antibody-drug conjugates (ADCs) targeting ...
Claudin is a protein family that contains at least 27 members and it was first identified by Furuse in 1998. It is a four-pass transmembrane protein that has been expressed at the epithelial ...
Other companies developing claudin 18.2-targeted therapies include Innovent, which started dosing patients with its IBI343 antibody in a phase 1 trial involving patients with various solid tumours ...
Other companies developing claudin 18.2-targeted therapies include China's Innovent Bio, which started dosing patients with its CD3xClaudin 18.2 bispecific antibody IBI389 in a phase 1 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback